These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19718705)

  • 1. VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.
    Koch M; Dettori D; Van Nuffelen A; Souffreau J; Marconcini L; Wallays G; Moons L; Bruyère F; Oliviero S; Noel A; Foidart JM; Carmeliet P; Dewerchin M
    J Pathol; 2009 Nov; 219(3):356-64. PubMed ID: 19718705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
    Baldwin ME; Halford MM; Roufail S; Williams RA; Hibbs ML; Grail D; Kubo H; Stacker SA; Achen MG
    Mol Cell Biol; 2005 Mar; 25(6):2441-9. PubMed ID: 15743836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
    Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
    J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.
    Crnic I; Strittmatter K; Cavallaro U; Kopfstein L; Jussila L; Alitalo K; Christofori G
    Cancer Res; 2004 Dec; 64(23):8630-8. PubMed ID: 15574770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.
    Björndahl MA; Cao R; Burton JB; Brakenhielm E; Religa P; Galter D; Wu L; Cao Y
    Cancer Res; 2005 Oct; 65(20):9261-8. PubMed ID: 16230387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
    Niki T; Iba S; Tokunou M; Yamada T; Matsuno Y; Hirohashi S
    Clin Cancer Res; 2000 Jun; 6(6):2431-9. PubMed ID: 10873096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
    Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factors-C and -D correlate with evidence of lymphangiogenesis and angiogenesis in pancreatic adenocarcinoma.
    Zhang B; Zhao WH; Zhou WY; Yu WS; Yu JM; Li S
    Cancer Detect Prev; 2007; 31(6):436-42. PubMed ID: 18061373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and tumour metastasis.
    Tille JC; Nisato R; Pepper MS
    Novartis Found Symp; 2004; 256():112-31; discussion 132-6, 259-69. PubMed ID: 15027486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
    Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
    Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
    Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
    EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.